New analytics capability strengthens the CKG Intelligence data and AI layer powering the KidneyOne platform

April 13, 2026--Constellation Kidney Group (CKG), a leading technology provider for dialysis organizations, today announced the launch of RCM Intelligence, a new analytics capability that expands the KidneyOne™ platform, CKG’s integrated operating system for kidney care providers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413081081/en/

A Data-Driven, Dialysis Specific Intelligence Platform That Transforms Billing Data into Actionable Financial Insight.

RCM Intelligence strengthens the CKG Intelligence data and AI layer that powers analytics across the platform and transforms dialysis billing data into actionable operational insights.

Built on data from CKG’s FOCUS dialysis billing system, RCM Intelligence provides dialysis organizations with real-time visibility into critical revenue cycle metrics including accounts receivable performance, denial trends, adjustment behavior, and payment efficiency. The platform allows providers to quickly identify revenue risks, operational inefficiencies, and payer-specific issues affecting financial performance.

“Dialysis organizations operate in one of the most complex reimbursement environments in US healthcare,” said Chris Lutz, SVP of Global Revenue at Constellation Kidney Group. “RCM Intelligence turns billing data into operational insights and allows leadership teams to understand how their revenue cycle is performing and where attention is needed.”

RCM Intelligence is delivered through the CKG Intelligence platform, which aggregates clinical, operational, and financial data across CKG’s software ecosystem. The same platform also powers Renal AI, CKG’s predictive analytics solution developed in partnership with Delorean AI, which helps providers identify dialysis patients at elevated risk of hospitalization and other adverse clinical events.

Together, these capabilities form part of KidneyOne, CKG’s platform that unifies the core technologies dialysis providers rely on. This includes clinical systems, billing operations, analytics, and AI-driven insights.

As adoption grows, the expanding dataset within CKG Intelligence enables dialysis providers to gain deeper visibility into operational trends, payer behavior, and revenue cycle performance across their organizations to make more informed decisions.

“Our vision is to create a unified intelligence layer for kidney care,” said David Abbott, General Manager and Managing Director at Constellation Kidney Group. “Over time, as more organizations contribute data through the platform, CKG Intelligence will enable dialysis providers with increasingly powerful benchmarking and performance insights across the kidney care ecosystem, supporting data-driven decisions and ultimately better patient and financial outcomes”

RCM Intelligence is now available to dialysis organizations using the FOCUS billing platform, with additional analytics capabilities planned as CKG continues expanding the KidneyOne ecosystem.

About Constellation Kidney Group

Constellation Kidney Group (CKG) is a global leader in dialysis technology, delivering purpose-built clinical, financial, and operational solutions that empower kidney care providers worldwide. Formed through the acquisition of leading software innovators beginning in 2013, CKG brings together decades of expertise in KidneyOne — an integrated platform offering modern EHR applications, data-driven intelligence, and seamless interoperability through CKG Exchange. CKG is a global portfolio of businesses under Miram Solutions within the Perseus Operating Group of Constellation Software Inc. (TSX: CSU), and is committed to advancing kidney care through innovation, reliability, and long-term partnership. Learn more at www.constellationkidney.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260413081081/en/

Real-time visibility into dialysis revenue cycle performance to identify risk, reduce denials, and improve cash flow.